Gut-adipose tissue axis in hepatic fat accumulation in humans.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Hepatology

• Publication date

  2014-07-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.jhep.2014.02.020PMID 24613361
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Faecalibacterium prausnitzii and human intestinal health.

  2013cited by this paper
• Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH

  2013cited by this paper
• Gut metagenome in European women with normal, impaired and diabetic glucose control

  2013cited by this paper
• Intestinal microbiota in patients with nonalcoholic fatty liver disease

  2013cited by this paper
• Richness of human gut microbiome correlates with metabolic markers

  2013cited by this paper
• Structural and inflammatory heterogeneity in subcutaneous adipose tissue: relation with liver histopathology in morbid obesity.

  2012cited by this paper
• Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: Decreased tumor metastasis in a breast cancer model

  2012cited by this paper
• Induction of VEGF and MMP-9 Expression by Toll-like Receptor 2/4 in Human Endothelial Cells Infected with Chlamydia Pneumoniae

  2012cited by this paper
• Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.

  2012cited by this paper
• LAPTM5 Protein Is a Positive Regulator of Proinflammatory Signaling Pathways in Macrophages*

  2012cited by this paper
• Size-dependent mechanism of cargo sorting during lysosome-phagosome fusion is controlled by Rab34

  2012cited by this paper
• Women With and Without Metabolic Disorder Differ in Their Gut Microbiota Composition

  2012cited by this paper
• Staphylococcus aureus directly activates eosinophils via platelet‐activating factor receptor

  2012cited by this paper
• Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment

  2011cited by this paper
• Contribution of Gut Bacteria to Liver Pathobiology

  2010cited by this paper
• Cathepsin X-deficient Gastric Epithelial Cells in Co-culture with Macrophages

  2010cited by this paper
• Beta‐arrestin 2 negatively regulates sepsis‐induced inflammation

  2010cited by this paper
• Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease

  2009cited by this paper
• Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

  2009cited by this paper
• Nonalcoholic fatty liver disease: rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging.

  2009cited by this paper
• The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection

  2009cited by this paper
• Yersinia enterocolitica differentially modulates RhoG activity in host cells

  2009cited by this paper
• GILT is a critical host factor for Listeria monocytogenes infection

  2008cited by this paper
• Assessing Body Composition With DXA and Bioimpedance: Effects of Obesity, Physical Activity, and Age

  2008cited by this paper
• Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice

  2008cited by this paper
• Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

  2008cited by this paper
• GI Epidemiology: nonalcoholic fatty liver disease

  2007cited by this paper
• Microbial balance index — A view on the intestinal microbiota☆

  2007cited by this paper
• The PH domain containing protein CKIP-1 binds to IFP35 and Nmi and is involved in cytokine signaling.

  2007cited by this paper
• CD52 is a novel costimulatory molecule for induction of CD4+ regulatory T cells.

  2006cited by this paper
• Quantification of bacteria in human feces using 16S rRNA-hybridization, DNA-staining and flow cytometry.

  2005cited by this paper
• limma: Linear Models for Microarray Data

  2005cited by this paper
• RNAi knockdown of the focal adhesion protein TES reveals its role in actin stress fibre organisation.

  2005cited by this paper
• Food consumption and nutrient intakes with a special focus on milk product consumption in early pubertal girls in Central Finland

  2005cited by this paper
• Nonalcoholic fatty liver disease: a review of current understanding and future impact.

  2004cited by this paper
• Visceral adipose tissue: relations between single-slice areas and total volume.

  2004cited by this paper
• Bioconductor: open software development for computational biology and bioinformatics

  2004cited by this paper
• The gut microbiota as an environmental factor that regulates fat storage.

  2004cited by this paper
• affy - analysis of Affymetrix GeneChip data at the probe level

  2004cited by this paper
• A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

  2003cited by this paper
• Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration

  2001cited by this paper
• THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY

  2001cited by this paper
• Prediction of total subcutaneous abdominal, intraperitoneal, and retroperitoneal adipose tissue masses in men by a single axial magnetic resonance imaging slice.

  1997cited by this paper
• Gentleman R: R: A language for data analysis and graphics

  1996cited by this paper

• Paeoniflorin Alleviates Metabolic Dysfunction-Associated Steatotic Liver Disease by Inhibiting Hepatic Lipogenesis and Inflammation.

  2026cites this paper
• Gut Microbiota Predicts Treatment Response to Empagliflozin Among MASLD Patients Without Diabetes Mellitus

  2025cites this paper
• Role of Gut-Liver Axis in Non-Alcoholic Fatty Liver Disease: A Mini Review

  2025cites this paper
• Oxidative Stress in Liver Metabolic Dysfunction and Diseases, with a Focus on Hepatogenic Diabetes: Effect of Alcohol Consumption

  2025cites this paper
• Role of Gut-Liver Axis in Non-Alcoholic Fatty Liver Disease

  2025cites this paper
• Prebiotic xylo-oligosaccharides for alleviation of hepatic steatosis: Results from a four-month dietary intervention and determinants of response

  2025cites this paper
• Gut microbiota and metabolic biomarkers in metabolic dysfunction–associated steatotic liver disease

  2024cites this paper
• Gut microbiome and NAFLD: impact and therapeutic potential

  2024cites this paper
• mARC1 in MASLD: Modulation of lipid accumulation in human hepatocytes and adipocytes

  2024cites this paper
• Double-blinded, randomized clinical trial of Gegen Qinlian decoction pinpoints Faecalibacterium as key gut bacteria in alleviating hyperglycemia

  2024cites this paper
• Fecal Metagenomics and Metabolomics Identifying Microbial Signatures in Non-Alcoholic Fatty Liver Disease

  2023cites this paper
• Markers of adipose tissue fibrogenesis associate with clinically significant liver fibrosis and are unchanged by synbiotic treatment in patients with NAFLD.

  2023cites this paper
• Analysis of microbiota profile and nutritional status in male professional football players.

  2023cites this paper
• Associations between abdominal obesity indices and pathological features of non‐alcoholic fatty liver disease: Chinese visceral adiposity index

  2023cites this paper
• DT-109 ameliorates nonalcoholic steatohepatitis in nonhuman primates.

  2023cites this paper
• Identification of Gut Microbial Lysine and Histidine Degradation and CYP-Dependent Metabolites as Biomarkers of Fatty Liver Disease

  2023cites this paper
• An outlook on fluorescent in situ hybridization coupled to flow cytometry as a versatile technique to evaluate the effects of foods and dietary interventions on gut microbiota

  2022cites this paper
• Gut microbiota–mitochondrial inter-talk in non-alcoholic fatty liver disease

  2022cites this paper
• Interaction effect between NAFLD severity and high carbohydrate diet on gut microbiome alteration and hepatic de novo lipogenesis

  2022cites this paper
• Xylo-Oligosaccharides in Prevention of Hepatic Steatosis and Adipose Tissue Inflammation: Associating Taxonomic and Metabolomic Patterns in Fecal Microbiomes with Biclustering

  2021cites this paper
• THE ROLE OF PROBIOTIC, PREBIOTIC, AND SYNBIOTIC SUPPLEMENTS IN OBESITY AND NON-ALCOHOLIC FATTY LIVER DISEASE

  2021cites this paper
• Microbiome Diagnostics and Interventions in Health and Disease

  2021cites this paper
• A Distinctive NAFLD Signature in Adipose Tissue from Women with Severe Obesity

  2021cites this paper
• Gut Microbiome-Based Diagnostic Model to Predict Diabetes Mellitus

  2021cites this paper
• PARPs in lipid metabolism and related diseases.

  2021cites this paper
• Soyasaponin A2 Alleviates Steatohepatitis Possibly through Regulating Bile Acids and Gut Microbiota in the Methionine and Choline Deficient (MCD) Diet-induced Non-alcoholic Steatohepatitis (NASH) Mice.

  2021cites this paper
• Relationship between body composition and the histology of non‐alcoholic fatty liver disease: a cross‐sectional study

  2021cites this paper
• An Update on the Efficacy and Functionality of Probiotics for the Treatment of Non-Alcoholic Fatty Liver Disease

  2020cites this paper
• Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis

  2020cites this paper
• Adipose tissue remodelling in obese subjects is a determinant of presence and severity of fatty liver disease

  2020cites this paper
• Prebiotic Xylo-Oligosaccharides Ameliorate High-Fat-Diet-Induced Hepatic Steatosis in Rats

  2020cites this paper
• Skeletal Muscle Dysfunction in the Development and Progression of Nonalcoholic Fatty Liver Disease

  2020cites this paper
• Prebiotic Xylo-oligosaccharides Targeting Faecalibacterium prausnitzii Prevent High Fat Diet-induced Hepatic Steatosis in Rats

  2020cites this paper
• The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage

  2020cites this paper
• NUTRIGENOMICS AS A TOOL IN THE PREVENTION OF LIPOTOXICITY: THE CASE OF SOY PROTEIN.

  2019cites this paper
• Fermented soybean powder containing Bacillus subtilis SJLH001 protects against obesity in mice by improving transport function and inhibiting angiogenesis

  2019cites this paper
• Vascular Adhesion Protein 1 Mediates Gut Microbial Flagellin-Induced Inflammation, Leukocyte Infiltration, and Hepatic Steatosis

  2019cites this paper
• Immune-Deficient Pfp/Rag2−/− Mice Featured Higher Adipose Tissue Mass and Liver Lipid Accumulation with Growing Age than Wildtype C57BL/6N Mice

  2019cites this paper
• A Data Integration Multi-Omics Approach to Study Calorie Restriction-Induced Changes in Insulin Sensitivity

  2019cites this paper
• Six-Week Endurance Exercise Alters Gut Metagenome That Is not Reflected in Systemic Metabolism in Over-weight Women

  2018cites this paper
• Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma

  2017cites this paper
• The gut microbiome composition associates with bipolar disorder and illness severity.

  2017cites this paper
• Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non‐alcoholic fatty liver disease

  2017influential citation
• Gut microbiota, obesity and metabolic disorders.

  2017cites this paper
• The Association between Cardiorespiratory Fitness and Gut Microbiota Composition in Premenopausal Women

  2017cites this paper
• Gut microbiota and the liver.

  2017cites this paper
• Faecalibacterium prausnitzii treatment improves hepatic health and reduces adipose tissue inflammation in high-fat fed mice

  2017cites this paper
• NAFLD, Helicobacter species and the intestinal microbiome.

  2017cites this paper
• Adipocytes as a Link Between Gut Microbiota-Derived Flagellin and Hepatocyte Fat Accumulation

  2016cites this paper
• Nonalcoholic Fatty Liver Disease and the Gut Microbiome.

  2016cites this paper
• Foie métabolique

  2016cites this paper
• The Microbiome in Obesity, Diabetes, and NAFLD: What is Your Gut Telling Us?

  2016cites this paper
• Losing weight for a better health: Role for the gut microbiota

  2016cites this paper
• Insulin resistance is associated with altered amino acid metabolism and adipose tissue dysfunction in normoglycemic women

  2016cites this paper
• Les hépatopathies stéatosiques non alcooliques et le microbiote intestinal

  2015cites this paper
• Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.

  2015cites this paper
• Adipose Tissue Dysfunction and Altered Systemic Amino Acid Metabolism Are Associated with Non-Alcoholic Fatty Liver Disease

  2015cites this paper
• [Health-Related Quality of Life in patients with hepatitis C treated with dual and triple therapy].

  2015cites this paper
• Toll‐like receptor 5 in obesity: The role of gut microbiota and adipose tissue inflammation

  2015cites this paper
• Advances in hepatic stem/progenitor cell biology

  2015cites this paper
• Pathological implications of cadherin zonation in mouse liver

  2015cites this paper
• Le microbiote et les stéatopathies métaboliques

  2014cites this paper
• Non-alcoholic fatty liver disease in patients with diabetes mellitus

  2014cites this paper
• [Not Available].

  2014cites this paper